Trials / Unknown
UnknownNCT04937712
Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction
Molecular Characterization and Cellular Infection Capacity of Urinary Viral Particles Isolated From SARS-CoV-2 and Association With Proximal Tubular Dysfunction, in Hospitalized Patients With COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The primary goal is to detect Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) urine viral particles in patients in intensive care units, hospitalized for coronavirus Coronavirus Disease-19 (COVID-19) infection, and correlate the presence of the virus in the urine with proximal tubular dysfunction (defined by the association of at least 2 abnormalities: tubular proteinuria, renal phosphate leak, uricosuria, normoglycemic glycosuria, amino aciduria)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RT-PCR SARS-COV2 in urine | proteinuria/renal phosphate leak/uricosuria/glycosuria/ aminoaciduria) |
Timeline
- Start date
- 2021-08-19
- Primary completion
- 2022-07-01
- Completion
- 2022-07-01
- First posted
- 2021-06-24
- Last updated
- 2021-08-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04937712. Inclusion in this directory is not an endorsement.